<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04423484</url>
  </required_header>
  <id_info>
    <org_study_id>GFANEPHRO2020</org_study_id>
    <nct_id>NCT04423484</nct_id>
  </id_info>
  <brief_title>Therapeutic Recommendations for Nephroblastoma</brief_title>
  <acronym>GFANEPHRO20</acronym>
  <official_title>Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Africa Pediatric Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>French Africa Pediatric Oncology Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is based on results form 2 previous studies carried out by the GFAOP. The aim of
      this study is to evaluate the capacity of units to follow the recommendations in the
      protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is based on results form 2 previous studies carried out by the GFAOP. This study
      aims to evaluate the capacity of units to follow the recommendations in the protocol. It will
      look mainly at treatment compliance and outcome for the children treated. The study will also
      evaluate the improvement in treatment compliance and reporting. This work will help the group
      to evaluate future needs in participating units and help us adapt treatment programmes to
      local conditions.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the number of cases with local disease.</measure>
    <time_frame>5 years</time_frame>
    <description>By evaluating the initial clinical reports and later histological reports to confirm the stage and the diagnosis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the number of cases with stage IV disease.</measure>
    <time_frame>5 Years</time_frame>
    <description>By evaluating the initial clinical reports and later histological reports to confirm the stage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluating the treatment given.</measure>
    <time_frame>5 Years</time_frame>
    <description>Comparison of treatment given and recommended treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluating the follow up after treatment.</measure>
    <time_frame>5 Years</time_frame>
    <description>How many children alive or dead after treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Why has treatment failed</measure>
    <time_frame>5 years</time_frame>
    <description>look at precision of reporting by comparing reports (histological and surgical)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Nephroblastoma</condition>
  <arm_group>
    <arm_group_label>Children with Nephroblastoma</arm_group_label>
    <description>All children coming into the participating units with suspected Nephroblastoma.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.</description>
    <arm_group_label>Children with Nephroblastoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All children with local Nephroblastoma in all participating units
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will
        permit treatment.

        .

        Exclusion Criteria:

        Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the
        diagnosis Treatment Refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>BRENDA MALLON, MSC</last_name>
    <phone>0033142115411</phone>
    <email>brenda.mallon@gustaveroussy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Treichville à ABIDJAN</name>
      <address>
        <city>Abidjan</city>
        <country>Côte D'Ivoire</country>
      </address>
    </facility>
    <contact>
      <last_name>Line Guei COUITCHERE, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Côte D'Ivoire</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 4, 2020</study_first_submitted>
  <study_first_submitted_qc>June 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wilms Tumor</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

